Rare Disease Therapeutics, Inc. Information

Rare Disease Therapeutics, Inc., on the other hand, is a company built on the hope and premise of providing options where there are no options, and providing therapies where there are no therapies, through creative strategic alliances, as well as unique relationships with the government, research institutions, physicians, scientist, and manufacturers. Rare Disease Therapeutics, Inc., is a well established company founded in 1991 as Orphan Pharmaceuticals, U.S.A., Inc., strategically located in Nashville, Tennessee. The company changed its name to Rare Disease Therapeutics, Inc., in March 2001 to better describe its mission. Rare Disease Therapeutics, Inc., has a solid track record with multiple licensing agreements, a comprehensive global patient advocacy network, and significant success in drug development and approval. The company's major clinical expertise and licensing focus have been in rare diseases in the following therapeutic areas: Oncology Genetic disorders Hematology Metabolic diseases Poison control Hepatic diseases In addition to the above cited therapeutic areas, Rare Disease Therapeutics, Inc., is also seeking current orphan products or low volume mature products that would be considered as orphans if these products were launched today.